Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-101945
Filing Date
2010-04-30
Accepted
2010-04-30 16:10:10
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 303228
2 CERTIFICATION OF OUR CEO PURSUANT TO RULE 13A-14 AND 15D-14 dex311.htm EX-31.1 7226
3 CERTIFICATION OF OUR CFO PURSUANT TO RULE 13A-14 AND 15D-14 dex312.htm EX-31.2 7206
4 CERTIFICATION OF OUR CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4059
5 CERTIFICATION OF OUR CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 4079
  Complete submission text file 0001193125-10-101945.txt   327286
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
MDRNA, Inc. (Filer) CIK: 0000737207 (see all company filings)

EIN.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-13789 | Film No.: 10787484
SIC: 2834 Pharmaceutical Preparations